255 related articles for article (PubMed ID: 10599469)
1. [Prognostic factors and markers used in urothelial carcinoma of the bladder].
Billerey C; Vieillefond A
Ann Pathol; 1999; 19(5 Suppl):S107-9. PubMed ID: 10599469
[No Abstract] [Full Text] [Related]
2. Bivariate analysis DNA/cytokeratin 7 and flow cytometric measurement of MIB-1 in superficial transitional carcinoma of the bladder (TCC). Methodological aspects and prognostic implications.
Leonardi E; Cristofori A; Reich A; Dalla Palma P
Eur J Histochem; 1997; 41 Suppl 2():133-4. PubMed ID: 9859817
[No Abstract] [Full Text] [Related]
3. Markers of prognosis in superficial bladder cancer.
Fradet Y
Semin Urol; 1992 Feb; 10(1):28-38. PubMed ID: 1565901
[No Abstract] [Full Text] [Related]
4. [Prognostic factors in the tertiary prevention of superficial transitional carcinoma of the bladder].
Comeri G; Belvisi P; Cappoli S; Conti G; Duvia R; Gianneo E; Radice GP
Arch Ital Urol Nefrol Androl; 1988 Jun; 60(2):147-68. PubMed ID: 2975849
[No Abstract] [Full Text] [Related]
5. Chromosome markers and progression in bladder cancer.
Sandberg AA
Cancer Res; 1977 Aug; 37(8 Pt 2):2950-6. PubMed ID: 872125
[No Abstract] [Full Text] [Related]
6. [Prognostic factors of urinary bladder carcinoma].
vom Dorp F; Jaeger T; Schmidt K; Siffert W; Rübben H
Urologe A; 2007 Sep; 46(9):1151. PubMed ID: 17641868
[No Abstract] [Full Text] [Related]
7. [Prognostic markers in transitional carcinoma of the bladder].
Blasco E; Gutiérrez-Hoyos A; Garrido C; Arozena F
Arch Esp Urol; 1991; 44(1):47-52. PubMed ID: 2064423
[TBL] [Abstract][Full Text] [Related]
8. [Significance and application of DNA ploidy of bladder cancer cells in studying the malignancy of tumors].
Cao S
Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):143-5. PubMed ID: 2163740
[No Abstract] [Full Text] [Related]
9. Critical appraisal of tumor markers in bladder cancer.
Fradet Y; Cordon-Cardo C
Semin Urol; 1993 Aug; 11(3):145-53. PubMed ID: 8105526
[No Abstract] [Full Text] [Related]
10. [Is protein p53 an independent prognostic factor in bladder carcinoma?].
Keilholz L
Strahlenther Onkol; 1995 Sep; 171(9):543-4. PubMed ID: 7570304
[No Abstract] [Full Text] [Related]
11. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
[TBL] [Abstract][Full Text] [Related]
12. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.
Dhawan D; Hamdy FC; Rehman I; Patterson J; Cross SS; Feeley KM; Stephenson Y; Meuth M; Catto JW
J Pathol; 2006 Jul; 209(3):336-43. PubMed ID: 16639696
[TBL] [Abstract][Full Text] [Related]
14. Genetic modeling of human urinary bladder carcinogenesis.
Czerniak B; Li L; Chaturvedi V; Ro JY; Johnston DA; Hodges S; Benedict WF
Genes Chromosomes Cancer; 2000 Apr; 27(4):392-402. PubMed ID: 10719370
[TBL] [Abstract][Full Text] [Related]
15. [Tumor markers and prognostic parameters in urinary bladder cancer].
Schneider AW; Huland H
Urologe A; 1990 Mar; 29(2):71-6. PubMed ID: 2184571
[TBL] [Abstract][Full Text] [Related]
16. Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma?
Soukup V; Babjuk M; Dusková J; Pesl M; Szakáczová M; Zámecník L; Dvorácek J
Urol Int; 2008; 80(4):413-8. PubMed ID: 18587253
[TBL] [Abstract][Full Text] [Related]
17. DNA-aneuploidy as marker for neoplasia in G1-urothelial carcinomas.
Planz B; Striepecke E; Wolff JM; Effert P; Jakse G; Böcking A
Gen Diagn Pathol; 1996 Oct; 142(2):69-73. PubMed ID: 8950570
[TBL] [Abstract][Full Text] [Related]
18. Studies on growth of human bladder tumors. The relationship between the proliferative cell population, the chromosome pattern and histology.
Neagu V; Lazar C; Mares V; Pop T; Ioanid PC
Neoplasma; 1979; 26(2):195-200. PubMed ID: 471126
[No Abstract] [Full Text] [Related]
19. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
[TBL] [Abstract][Full Text] [Related]
20. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology.
Kawauchi S; Sakai H; Ikemoto K; Eguchi S; Nakao M; Takihara H; Shimabukuro T; Furuya T; Oga A; Matsuyama H; Takahashi M; Sasaki K
Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
